Mutational analysis of the tumor suppressor Smad2 in acute lymphoid and myeloid leukemia

Leukemia

Volumn 12, Issue 7, 1998, Pages 1114-1118

  Wieser, R ^a   Gruber, B ^a   Rieder, H ^b   Fonatsch, C ^a  

^a Inst fur Medizinische Psychologie   (Austria)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

ALL; AML; Leukemia; Smad2; Tumor suppressor

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; CLINICAL ARTICLE; GENE MUTATION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0031824917     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401073     Document Type: Article

References (14)

1. Massagué J. TGF-β signalling: receptors, transducers, and Mad Proteins. Cell 1996; 85: 947-950.
2. Derynck R, Zhang Y. Intracellular signalling: the Mad way to do it. Curr Biol 1996; 6: 1226-1229.
3. Hahn S, Schutte M, Hoque A, Moskaluk C, da Costa L, Rozenblum E, Weinstein C, Fischer A, Yeo C, Hruban R, Kern S. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996; 271: 350-353.
4. Massagué J. The transforming growth factor-beta family. Annu Rev Cell Biol 1990; 6: 597-641.
5. Hooper W. The role of transforming growth factor-beta in hematopoiesis. Leukemia Res 1991; 15: 179-184.
6. Robson H, Anderson E, James R, Schofield P. Transforming growth factor beta 1 expression in human colorectal tumours: an independent prognostic marker in a subgroup of poor prognosis patients. Br J Cancer 1996; 74: 753-758.
7. Manning A, Williams A, Game S, Paraskeva C. Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor beta (TGF-β): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-β. Oncogene 1991; 6: 1471-1476.
8. Fynan T, Reiss M. Resistance to inhibition of cell growth by transforming growth factor-beta and its role in oncogenesis. Crit Rev Oncog 1993; 4: 493-540.
9. Terui T, Niitsu Y, Mahara K, Fujisaki Y, Urushizaki Y, Mogi Y, Kohgo Y, Watanabe N, Ogura M, Saito H. The production of transforming growth factor-beta in acute megakaryoblastic leukemia and its possible implications in myelofibrosis. Blood 1990; 75: 1540-1548.
10. Martyre M. TGF-β and megakaryocytes in the pathogenesis of myelofibrosis. Leuk Lymphoma 1995; 20: 39-44.
11. Sing G, Keller J, Ellingsworth L, Ruscetti F. Transforming growth factor beta selectively inhibits normal and leukemic human bone marrow cell growth in vitro. Blood 1988; 72: 1504-1511.
12. Piacibello W, Severino A, Stacchini A, Aglietta M. Differential effect of transforming growth factor beta 1 on the proliferation of human lymphoid and myeloid leukemia cells. Haematologica 1991; 76: 460-166.
13. Israels L, Israels S, Begleiter A, Verburg L, Schwartz L, Mowat M, Johnston J. Role of transforming growth factor-beta in chronic lymphocytic leukemia. Leukemia Res 1993; 17: 81-87.
14. Douglas R, Capocasale R, Lamb R, Nowell P, Moore J. Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-beta. Blood 1997; 89: 941-947.